1.
Miranda Poma J, Ostios Garcia L, Villamayor Sanchez J, D’errico G. What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events. Allergol Immunopathol [Internet]. 2019 Jun. 15 [cited 2026 Apr. 26];47(3):303-8. Available from: https://all-imm.com/index.php/aei/article/view/309